Recovery from the coronavirus disease‐2019 (COVID‐19) in two patients with coexisted (HIV) infection

Abstract

COVID-19 has become a global health concern. HIV-infected patients are particularly vulnerable to COVID-19 due to their immune-compromised status.

COVID‐19 in three people living with HIV in the United Kingdom

“…Two of the regimens contained tenofovir which has theoretical antiviral activity. 1,2 They all remained on preadmission ART regimens in accordance with guidance from the British HIV Association. We suggest that HIV alone does not result in amplified risk of infection or adverse outcomes in COVID-19 infection when compared with the general population.…”

COVID‐19 and HIV co‐infection an emerging consensus

“…The above observation is consistent with the clinical cure of at least four patients with COVID-19, who were newly diagnosed with HIV. [13][14][15][16] These early observations regarding aspects of morbidity and mortality in severe acute respiratory syndrome coronavirus 2 and PLWH are encouraging. However, more research is needed to clarify clinical and therapeutic aspects including drug-drug interactions (pharmacokinetic and pharmacogenomic data as well as genetic polymorphism).…”

Clinical outcomes and prognosis of patients with HIV and SARS‐CoV‐2 coinfection

“…5 These studies include, but are not limited to: Vizcarra et al, 6 who report 51 HIV patients diagnosed with COVID-19 in Italy; Suwanwongse et al, 7 who report 9 HIV/SARS-CoV-2 coinfected patients in the United States; Härter et al, 8 who report a case series of 33 HIV/SARS-CoV-2 coinfected patients in Germany; Shalev et al, 9 who report 31 HIV/SARS-CoV-2 coinfected patients in the United States; Gervasoni et al, 10 who report 45 HIV/SARS-CoV-2 coinfected patients in Italy; and several other case reports of HIV/SARS-CoV-2 coinfection across the world published early in the pandemic. [11][12][13][14][15][16]…”